Maxposure

When is the next results date for Maxposure?

No Upcoming Board Meetings

Has Maxposure declared dividend?

No Dividend History Available

Who are the peers of the Maxposure?

Maxposure's peers include Sun TV Network, Zee Entertainment, Nazara Technologies, Saregama India, PVR Inox, Cinevista, Digikore Studios, Vels Film, and Baweja Studios. Notable performance includes Nazara Technologies with a 61.87% 1-year return, while PVR Inox has the lowest at -24.12%.

Peers: The peers of Maxposure are Sun TV Network, Zee Entertainmen, Nazara Technolo., Saregama India, PVR Inox, Cinevista, Digikore Studios, Vels Film, Baweja Studios L, Picturepost.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun TV Network, Saregama India, and Baweja Studios L, while Average management risk is found at Zee Entertainmen, Nazara Technolo., PVR Inox, Digikore Studios, and Vels Film, and Below Average management risk is noted at Cinevista. Good growth is seen at Nazara Technolo., Saregama India, and Baweja Studios L, while Below Average growth is present at Sun TV Network, Zee Entertainmen, PVR Inox, Cinevista, Digikore Studios, and Vels Film, and the rest. Excellent capital structure is held by Sun TV Network, Zee Entertainmen, Nazara Technolo., Saregama India, and Baweja Studios L, while Below Average capital structure is noted at PVR Inox, Cinevista, and Vels Film, and the rest.<BR><BR>Return Snapshot: Nazara Technolo. has the highest 1-year return at 61.87%, while PVR Inox has the lowest at -24.12%, with Maxposure's own 1-year return being 0.00%, which is better than PVR Inox but worse than Nazara Technolo. Additionally, the six-month return is negative for PVR Inox, Cinevista, and the rest.

What is the technical trend for Maxposure?

As of May 16, 2025, Maxposure's technical trend is mildly bearish, indicated by daily moving averages and weekly Bollinger Bands, despite a mildly bullish weekly MACD and no significant signals from RSI, Dow Theory, or OBV.

As of 16 May 2025, the technical trend for Maxposure has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the daily moving averages are showing a mildly bearish trend. The Bollinger Bands on the weekly chart are also bearish, suggesting some downward pressure. The RSI does not provide any signals on both the weekly and monthly time frames, and there are no trends indicated by Dow Theory or OBV. Overall, the current technical stance is mildly bearish, with key indicators being the daily moving averages and the weekly Bollinger Bands.

What does Maxposure do?

Maxposure Ltd, a Micro Cap company in the Media & Entertainment industry, was incorporated in 2006 and recently renamed in 2023. It has a market cap of INR 152 Cr, with key metrics including a P/E of 19.00 and a return on equity of 27.82%.

Overview:<BR>Maxposure Ltd operates in the Media & Entertainment industry and is categorized as a Micro Cap company.<BR><BR>History:<BR>Maxposure Limited was incorporated on August 17, 2006, under the name 'Maxposure Media Group India Private Limited'. The company later changed its name to 'Maxposure Private Limited' on October 26, 2023. Revenue and profit data for the latest quarter are not available.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 152 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 19.00<BR>Industry P/E: 86<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.01<BR>Return on Equity: 27.82%<BR>Price to Book: 4.63<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Who are the top shareholders of the Maxposure?

The top shareholders of Maxposure include Prakash Johari with 37.43%, Shubhi Johari with 6.16%, and individual investors holding 24.01%. There are no pledged promoter holdings or mutual funds invested in the company.

The top shareholders of Maxposure include the promoters, with Prakash Johari holding the largest stake at 37.43%. The highest public shareholder is Shubhi Johari, who owns 6.16%. Additionally, individual investors collectively hold 24.01% of the shares. There are also two foreign institutional investors (FIIs) that hold a combined 0.91% of the company. Notably, there are no pledged promoter holdings and no mutual funds currently invested in Maxposure.

How big is Maxposure?

As of 24th July, Maxposure Ltd has a market capitalization of 139.00 Cr, classifying it as a Micro Cap company, with Shareholder's Funds of 56.63 Cr and Total Assets of 74.32 Cr; however, there is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 24th July, <BR><BR>Market Cap: Maxposure Ltd has a market capitalization of 139.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 56.63 Cr and Total Assets valued at 74.32 Cr.

Is Maxposure overvalued or undervalued?

As of September 9, 2025, Maxposure is considered a very attractive investment due to its undervalued status, strong financial ratios like a PE of 15.88 and ROCE of 26.06%, and favorable comparison to peers, despite a year-to-date stock decline of -33.66%.

As of 9 September 2025, the valuation grade for Maxposure has moved from fair to very attractive, indicating a significant improvement in its investment appeal. The company is currently assessed as undervalued, especially when considering its key financial ratios. The PE ratio stands at 15.88, the EV to EBITDA ratio is 10.63, and the ROCE is a robust 26.06%, suggesting strong operational efficiency and profitability.<BR><BR>In comparison to its peers, Maxposure's valuation metrics are favorable. For instance, PVR Inox, classified as attractive, has a PE ratio that is not applicable due to losses, while Prime Focus, rated fair, has a much higher PE ratio of 32.17. This highlights Maxposure's relative value in the media and entertainment sector. Despite a recent decline in stock performance, with a year-to-date return of -33.66% compared to a 5.18% gain in the Sensex, the underlying financial indicators suggest that Maxposure presents a compelling investment opportunity at its current price of 58.35.

How has been the historical performance of Maxposure?

Maxposure's historical performance from March 2024 to March 2025 shows significant growth in net sales from 47.28 Cr to 63.28 Cr and an increase in profit after tax from 8.11 Cr to 8.50 Cr, despite rising costs and negative cash flow from operating activities. Total assets and liabilities both rose, indicating overall growth, but the operating profit margin decreased.

Answer:<BR>The historical performance of Maxposure shows a positive trend in net sales and profit metrics from March 2024 to March 2025.<BR><BR>Breakdown:<BR>Maxposure's net sales increased significantly from 47.28 Cr in March 2024 to 63.28 Cr in March 2025, reflecting a strong growth in total operating income, which also rose from 47.28 Cr to 63.28 Cr. The total expenditure, excluding depreciation, rose from 36.54 Cr to 52.56 Cr, primarily driven by higher manufacturing expenses, which increased from 24.46 Cr to 37.24 Cr, and employee costs, which grew from 5.99 Cr to 8.05 Cr. Despite these rising costs, the operating profit (PBDIT) improved from 11.61 Cr to 12.07 Cr, although the operating profit margin decreased from 22.72% to 16.94%. Profit before tax slightly declined from 11.42 Cr to 11.00 Cr, while profit after tax increased from 8.11 Cr to 8.50 Cr, resulting in an increase in earnings per share from 3.57 to 3.74. The company's total assets increased from 74.32 Cr to 99.75 Cr, with total liabilities rising from 74.32 Cr to 99.75 Cr as well, indicating a growth in both assets and liabilities. Cash flow from operating activities turned negative, dropping from 0.00 Cr to -17.00 Cr, while cash flow from financing activities improved from 14.00 Cr to 16.00 Cr, leading to a net cash outflow of 4.00 Cr compared to an inflow of 16.00 Cr in the previous year. Overall, Maxposure demonstrated growth in sales and profits, despite challenges in managing costs and cash flow.

Why is Maxposure Ltd falling/rising?

As of 11-Feb, Maxposure Ltd's stock price is rising slightly to 36.95, but it has experienced significant declines over various periods, including a year-to-date drop of 17.89% and a 46.45% fall over the past year. Despite today's increase, the stock remains in a bearish trend, trading below its moving averages and close to its 52-week low.

As of 11-Feb, Maxposure Ltd's stock price is currently rising, with a change of 0.35 (0.96%) to a current price of 36.95. Despite this increase, the stock has shown a significant decline over various periods, including a 1-week drop of 4.77% and a 1-month decline of 9.77%. Year-to-date, the stock is down 17.89%, and over the past year, it has fallen by 46.45%. <BR><BR>The stock is also trading lower than its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish trend overall. However, there has been a notable increase in investor participation, with delivery volume on February 10 rising by 413.16% compared to the 5-day average, suggesting a potential interest in the stock despite its recent performance. <BR><BR>Additionally, the stock is close to its 52-week low, being only 2.57% away from it, which may contribute to the volatility in its price. Overall, while there is a slight rise in the stock price today, the broader context shows a persistent downward trend over longer periods.

Which are the latest news on Maxposure?